PAVmed appoints Shaun O'Neil as COO; $325K salary, 300K share option

PAVmed Inc.

Shaun O'Neil appointed COO effective Feb 22, 2022; previously Chief Commercial Officer since 2018.
Employment agreement: $325,000 base salary, annual performance bonus up to 50% of base.
Granted option to purchase 300,000 shares at $1.48 exercise price, vesting quarterly over 3 years.
Initial term through Feb 2025, auto-renew; severance of 12 months base if terminated without cause.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Shaun O’Neil

Chief Operating Officer

PAVM · PAVmed Inc.

Effective: 2022-02-22
Filed: February 24, 2022, 6:59 PM ET

On February 22, 2022, the board of directors (the “Board”) of PAVmed Inc. (the “Company”) appointed Shaun O’Neil as the Company’s Chief Operating Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Shaun O’Neil was appointed as Chief Operating Officer at PAVmed Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On February 22, 2022, the board of directors (the “Board”) of PAVmed Inc. (the “Company”) appointed Shaun O’Neil as the Company’s Chief Operating Officer.

View on SEC.gov

PAVmed Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-005399

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.